Autoimmune Movement Disorders

Overview

This presentation will discuss the spectrum of autoimmune movement disorders and explore diagnosis and treatment.

Presenters

Andrew McKeon, M.D., M.B., B.Ch.
Professor of Neurology
Associate Professor of Laboratory Medicine and Pathology
Mayo Clinic, Rochester, Minnesota

Learning Objectives

Upon completion of this activity, participants should be able to:

• Recognize autoimmune movement disorders.
• Review the spectrum of autoimmune movement phenotypes.
• Evaluate and treat a patient with a suspected autoimmune movement disorder.

Intended Audience

This webinar is designed for any provider who sees patients with a neurologic disease (e.g., neurologists, psychiatrists, primary care physicians including internists and family care practitioners) as well as pathologists, laboratory directors, and laboratory sendout coordinators.

Level of instruction

Intermediate-advanced

Credit

The following types of credit are offered for this event:
ASCLS P.A.C.E.®
State of California
State of Florida

To obtain credit:

1. Watch the video.
2. Complete the posttest and evaluation that launches immediately following the video.
3. Generate and print your certificate(s).

ASCLS P.A.C.E.®

Mayo Medical Laboratories is approved as a provider of continuing education programs in the Clinical Laboratory Sciences by the ASCLS P.A.C.E. ® program. This program has been approved for a maximum of 1 P.A.C.E® contact hour.

State of California

Mayo Medical Laboratories is approved as a Continuing Education Accrediting Agency for Clinical Laboratory Sciences for State of California. This program has been approved for 1 contact hour.

State of Florida

Mayo Medical Laboratories is approved as a Continuing Education Accrediting Agency for the clinical laboratory sciences for the State of Florida. Florida Board of Clinical Laboratory Personnel has designated this program for General credit. This program has been approved for 1 contact hour.

Faculty Disclosure

Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty members also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentations. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentations.

National Physician Payment Transparency Program

Mayo Medical Laboratories is not an applicable manufacturer or applicable group purchasing organization (GPO). (GPOs, per the Centers for Medicare & Medicaid Services, and this program do not trigger any reporting requirements pursuant to Open Payments [Sunshine Act] legislation.)